479 related articles for article (PubMed ID: 20624292)
21. A novel M2e-multiple antigenic peptide providing heterologous protection in mice.
Wen F; Ma JH; Yu H; Yang FR; Huang M; Zhou YJ; Li ZJ; Wang XH; Li GX; Jiang YF; Tong W; Tong GZ
J Vet Sci; 2016 Mar; 17(1):71-8. PubMed ID: 27051342
[TBL] [Abstract][Full Text] [Related]
22. Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine.
Yao Y; Wang H; Chen J; Shao Z; He B; Chen J; Lan J; Chen Q; Chen Z
Emerg Microbes Infect; 2019; 8(1):45-54. PubMed ID: 30866759
[TBL] [Abstract][Full Text] [Related]
23. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
24. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.
Guo Y; He L; Song N; Li P; Sun S; Zhao G; Tai W; Jiang S; Du L; Zhou Y
Microbes Infect; 2017 Dec; 19(12):641-647. PubMed ID: 28903071
[TBL] [Abstract][Full Text] [Related]
25. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.
Tumpey TM; Renshaw M; Clements JD; Katz JM
J Virol; 2001 Jun; 75(11):5141-50. PubMed ID: 11333895
[TBL] [Abstract][Full Text] [Related]
26. Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.
Zhao G; Du L; Xiao W; Sun S; Lin Y; Chen M; Kou Z; He Y; Lustigman S; Jiang S; Zheng BJ; Zhou Y
Vaccine; 2010 Oct; 28(44):7233-40. PubMed ID: 20732469
[TBL] [Abstract][Full Text] [Related]
27. A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
Kistner O; Crowe BA; Wodal W; Kerschbaum A; Savidis-Dacho H; Sabarth N; Falkner FG; Mayerhofer I; Mundt W; Reiter M; Grillberger L; Tauer C; Graninger M; Sachslehner A; Schwendinger M; Brühl P; Kreil TR; Ehrlich HJ; Barrett PN
PLoS One; 2010 Feb; 5(2):e9349. PubMed ID: 20186321
[TBL] [Abstract][Full Text] [Related]
28. Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.
Zhang J; Fan HY; Zhang Z; Zhang J; Zhang J; Huang JN; Ye Y; Liao M
Vaccine; 2016 Jan; 34(5):622-629. PubMed ID: 26724200
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
30. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
Shi J; Wen Z; Guo J; Zhang Y; Deng G; Shu Y; Wang D; Jiang Y; Kawaoka Y; Bu Z; Chen H
Antiviral Res; 2012 Mar; 93(3):346-53. PubMed ID: 22281419
[TBL] [Abstract][Full Text] [Related]
31. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.
Mozdzanowska K; Zharikova D; Cudic M; Otvos L; Gerhard W
Virol J; 2007 Oct; 4():118. PubMed ID: 17974006
[TBL] [Abstract][Full Text] [Related]
32. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
Sarawar S; Hatta Y; Watanabe S; Dias P; Neumann G; Kawaoka Y; Bilsel P
Vaccine; 2016 Sep; 34(42):5090-5098. PubMed ID: 27595896
[TBL] [Abstract][Full Text] [Related]
33. Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.
Ding H; Tsai C; Zhou F; Buchy P; Deubel V; Zhou P
PLoS One; 2011 Mar; 6(3):e17821. PubMed ID: 21464977
[TBL] [Abstract][Full Text] [Related]
34. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
35. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
36. Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
Hashemi H; Pouyanfard S; Bandehpour M; Noroozbabaei Z; Kazemi B; Saelens X; Mokhtari-Azad T
PLoS One; 2012; 7(9):e45765. PubMed ID: 23029232
[TBL] [Abstract][Full Text] [Related]
37. Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
Lee YT; Kim KH; Ko EJ; Kim MC; Lee YN; Hwang HS; Lee Y; Jung YJ; Kim YJ; Santos J; Perez DR; Kang SM
Virology; 2019 Mar; 529():111-121. PubMed ID: 30685658
[TBL] [Abstract][Full Text] [Related]
38. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice.
Ameghi A; Pilehvar-Soltanahmadi Y; Baradaran B; Barzegar A; Taghizadeh M; Zarghami N; Aghaiypour K
Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011
[TBL] [Abstract][Full Text] [Related]
39. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
[TBL] [Abstract][Full Text] [Related]
40. Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.
Easterbrook JD; Schwartzman LM; Gao J; Kash JC; Morens DM; Couzens L; Wan H; Eichelberger MC; Taubenberger JK
Virology; 2012 Oct; 432(1):39-44. PubMed ID: 22727831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
